PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation

Nikolaos Patsoukis(Beth Israel Deaconess Medical Center), Kankana Bardhan(Beth Israel Deaconess Medical Center), Pranam Chatterjee(Beth Israel Deaconess Medical Center), Duygu Sari(Beth Israel Deaconess Medical Center), Bianling Liu(Beth Israel Deaconess Medical Center), Lauren N. Bell(Metabolon (United States)), Edward D. Karoly(Metabolon (United States)), Gordon J. Freeman(Dana-Farber Cancer Institute), Victoria Petkova(Beth Israel Deaconess Medical Center), Pankaj Seth(Beth Israel Deaconess Medical Center), Lequn Li(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
Nature Communications
March 26, 2015
Cited by 1,151Open Access
Full Text

Abstract

During activation, T cells undergo metabolic reprogramming, which imprints distinct functional fates. We determined that on PD-1 ligation, activated T cells are unable to engage in glycolysis or amino acid metabolism but have an increased rate of fatty acid β-oxidation (FAO). PD-1 promotes FAO of endogenous lipids by increasing expression of CPT1A, and inducing lipolysis as indicated by elevation of the lipase ATGL, the lipolysis marker glycerol and release of fatty acids. Conversely, CTLA-4 inhibits glycolysis without augmenting FAO, suggesting that CTLA-4 sustains the metabolic profile of non-activated cells. Because T cells utilize glycolysis during differentiation to effectors, our findings reveal a metabolic mechanism responsible for PD-1-mediated blockade of T-effector cell differentiation. The enhancement of FAO provides a mechanistic explanation for the longevity of T cells receiving PD-1 signals in patients with chronic infections and cancer, and for their capacity to be reinvigorated by PD-1 blockade.


Related Papers